No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a Tunisian population

J Neural Transm (Vienna). 2013 Sep;120(9):1355-8. doi: 10.1007/s00702-013-0985-1. Epub 2013 Jan 31.

Abstract

We examined the potential involvement of the polymorphism in intron 8 of the presenilin-1 (PSEN1) gene as a risk factor for Alzheimer disease (AD), both through independent effect and interaction with the apolipoprotein E (APOE) ε4 allele risk, in 85 patients and 90 controls. We found no significant differences in the distribution of PSEN1 genotype and allele frequency between both groups; and post stratification distribution with APOE ε4 allele. Age of onset suggests that this polymorphism influences AD progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics*
  • Apolipoproteins E / genetics
  • DNA / genetics
  • Female
  • Genotype
  • Humans
  • Male
  • Polymorphism, Genetic / genetics*
  • Presenilin-1 / genetics*
  • Tunisia / epidemiology

Substances

  • Apolipoproteins E
  • Presenilin-1
  • DNA